GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » Cyclically Adjusted Book per Share

Medeon Biodesign (ROCO:6499) Cyclically Adjusted Book per Share : NT$28.57 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Medeon Biodesign's adjusted book value per share for the three months ended in Mar. 2024 was NT$23.155. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$28.57 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-21), Medeon Biodesign's current stock price is NT$49.90. Medeon Biodesign's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was NT$28.57. Medeon Biodesign's Cyclically Adjusted PB Ratio of today is 1.75.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Medeon Biodesign was 1.73. The lowest was 1.40. And the median was 1.60.


Medeon Biodesign Cyclically Adjusted Book per Share Historical Data

The historical data trend for Medeon Biodesign's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeon Biodesign Cyclically Adjusted Book per Share Chart

Medeon Biodesign Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medeon Biodesign Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 28.50 28.57

Competitive Comparison of Medeon Biodesign's Cyclically Adjusted Book per Share

For the Medical Instruments & Supplies subindustry, Medeon Biodesign's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medeon Biodesign's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medeon Biodesign's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medeon Biodesign's Cyclically Adjusted PB Ratio falls into.



Medeon Biodesign Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medeon Biodesign's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=23.155/131.7762*131.7762
=23.155

Current CPI (Mar. 2024) = 131.7762.

Medeon Biodesign Quarterly Data

Book Value per Share CPI Adj_Book
201306 0.000 98.518 0.000
201312 21.964 98.326 29.436
201406 5.834 100.560 7.645
201412 5.122 99.070 6.813
201503 0.000 99.621 0.000
201506 14.311 100.684 18.730
201509 0.000 100.392 0.000
201512 12.879 99.792 17.007
201603 12.176 100.470 15.970
201606 11.532 101.688 14.944
201609 21.307 101.861 27.565
201612 20.323 101.863 26.291
201703 19.544 102.862 25.038
201706 18.782 103.349 23.948
201709 17.969 104.136 22.738
201712 16.929 104.011 21.448
201803 21.582 105.290 27.011
201806 21.355 106.317 26.469
201809 20.736 106.507 25.656
201812 20.623 105.998 25.638
201903 24.445 107.251 30.035
201906 23.089 108.070 28.154
201909 22.280 108.329 27.102
201912 21.747 108.420 26.432
202003 21.180 108.902 25.629
202006 20.447 108.767 24.772
202009 19.398 109.815 23.277
202012 22.319 109.897 26.762
202103 22.269 111.754 26.259
202106 48.810 114.631 56.110
202109 46.120 115.734 52.513
202112 44.886 117.630 50.284
202203 45.109 121.301 49.004
202206 42.249 125.017 44.533
202209 41.202 125.227 43.357
202212 39.095 125.222 41.141
202303 36.848 127.348 38.129
202306 29.532 128.729 30.231
202309 27.616 129.860 28.024
202403 23.155 131.776 23.155

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Medeon Biodesign  (ROCO:6499) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medeon Biodesign's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=49.90/28.57
=1.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Medeon Biodesign was 1.73. The lowest was 1.40. And the median was 1.60.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Medeon Biodesign Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Medeon Biodesign's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Medeon Biodesign (ROCO:6499) Business Description

Traded in Other Exchanges
N/A
Address
No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170
Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign (ROCO:6499) Headlines

No Headlines